Wearables battle isn't like any other tech fight; FDA won't regulate MDDS;

News From Around the Web

> It's not surprising big tech titans are jumping into the mHealth segment in what will clearly be a competitive battle in the wearable devices market. But what will be different from other industries where big names have battled for dominance is that platforms in mHealth won't be entirely consumer-driven, according to a new CITEworld post. That's because it isn't just the patient who'll be adopting and using such technologies, and that's where the difference comes into play. Article

Health IT News

> Draft guidance by the U.S. Food and Drug Administration seemingly paves the way for smoother medical device interoperability by lowering the burden on developers of medical device data systems (MDDS) to comply with agency requirements. The guidance, published late last week, allows MDDS developers to focus on improving interoperability with other medical devices, according to Bakul Patel, senior policy adviser to the director of the Center for Devices and Radiological Health at FDA. Article

Provider News

> Readmissions could drop as much as 20 percent if community pharmacists work with high-risk patients after discharge on counseling and medication management, according to a new study. Researchers from the University of Cincinnati's James L. Winkle College of Pharmacy said hospitals were less likely to readmit patients who saw a pharmacist after discharge than those who didn't. Article

Health Insurance News

> Looking to create a more economically stable and person-centered healthcare system, Cambia Health, which includes Regence Blue Cross Blue Shield, is setting its sights on new investments to make this transformation happen. The various mega-trends include price transparency, value-based care and private exchanges, to name a few. But Cambia is most interested in the trend driving consumers to have a much more empowered role in their healthcare. Article

And Finally... Resourceful! Article